Using Platelet Rich Plasma to Improve Ovarian Function in Perimenopausal Women
Official title: Investigating Improvement of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Perimenopausal Women
Run by Genesis Athens Clinic · NCT03951194 · Data updated 2026-11-12
This study is testing if injecting a special treatment made from a woman's own blood can help improve ovarian function and hormone levels in women going through perimenopause.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years to 50 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Genesis Athens Clinic Academic / other |
| Locations | 1 site (Athens) |
| Status | Recruiting |
| Started | June 13, 2019 |
| Main results expected | January 30, 2027 |
| Study ends | July 30, 2028 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT03951194 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 40 and older with irregular menstrual cycles and elevated FSH levels.
✕Probably not a fit
Patients with reproductive system anatomical disorders, amenorrhea, or a history of certain reproductive cancers may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of autologous platelet rich plasma (PRP) intra ovarian infusion in enhancing ovarian tissue functionality and hormonal profiles in perimenopausal women. The study employs a triple-blind randomized controlled trial design, comparing the effects of PRP with a placebo treatment of autologous platelet free plasma (PFP). PRP, enriched with growth factors, is hypothesized to stimulate tissue proliferation and promote folliculogenesis. The trial aims to provide insights into the potential benefits of PRP for women experiencing infertility and menstrual cycle abnormalities during perimenopause.
Why it matters
Potential benefit: If successful, this treatment could improve ovarian function and hormonal balance in perimenopausal women, potentially enhancing fertility.
How similar studies have gone: While PRP has shown promise in other medical fields, its application for ovarian rejuvenation is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women ≥40 years of age, presenting with cycle irregularities while fulfilling at least one of the respective two criteria: more than seven days difference in menstrual cycle duration between two consecutive cycles OR, presence of a menstrual cycle duration over sixty days and progressive elevation of FSH levels. * Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment. * Willing to comply with study requirements Exclusion Criteria: * Any pathological disorder related to reproductive system anatomy * Amenorrhea * Endometriosis * Adenomyosis * Fibroids and adhesions * Infections in reproductive system * Current or previous diagnosis of cancer in reproductive system * History of familiar cancer in reproductive system * Severe male factor infertility * Prior referral for PGT * Ovarian inaccessibility * Previous POI diagnosis -Endocrinological disorders (Hypothalamus- * Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome) * BMI\>30 kg/m2 or BMI\<18.5 kg/m2 * Systematic autoimmune disorders
Where it's running
-
Genesis AC
Athens, Greece Recruiting
Study contacts
- Study coordinator: Mara Simopoulou, PhD
- Email: marasimopoulou@hotmail.com
- Phone: +306979234100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI into Ultrasound Diagnostics in Reproductive Medicine
Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.
-
Whole-Body Vibration and Relaxation for Adolescent Girls with Triad
This study tests whether a program of whole-body vibration plus relaxation can help improve bone health, periods, and well-being in adolescent female athletes with Female Athlete Triad Syndrome.
-
Tadalafil to increase uterine lining and improve frozen embryo transfer success
This test sees if adding daily tadalafil to standard estrogen helps women with unexplained infertility using good-quality day‑5 frozen embryos get a thicker uterine lining and better transfer outcomes.
-
FET-LET-2x2: Testing natural vs medicated natural cycles for frozen embryo transfer
This study tests four approaches to preparing the uterus for frozen embryo transfer to see which yields the best pregnancy rate in women undergoing IVF.
-
Integrative care guided by biological aging markers for unexplained female infertility
This trial tests whether measuring telomeres and other biological aging markers can guide a personalized integrative treatment to help women aged 25–42 with persistent unexplained infertility improve their chances of pregnancy.
-
How fitness, heart health, and mental well-being relate to assisted fertility treatments
This study tries to see if physical activity, cardiorespiratory fitness, cardiovascular health, sleep, and stress affect pregnancy chances for women undergoing assisted fertility treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.